← Eichor
Study identifier: NCT07285031 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Histamines and Central Hemodynamics

Condition: Histamine · Exercise  ·  Sponsor: University of British Columbia

PhaseNA
Planned participants20
Who can joinAll sexes, 19 Years to 39 Years
Healthy volunteersYes

About this study

When we exercise, more blood flow goes to our muscles, challenging our blood vessels. Following exercise, blood flow remains elevated and seems to be the reason for many of the positive cardiovascular benefits that occur with exercise. When the actions of histamine, a molecule primarily known for its role in allergies, are blocked, there is an attenuated blood flow response following exercise. However, this effect has never been studied in the blood vessels that supply our lungs. The purpose of this study is to examine the effects of histamines on pulmonary hemodynamics following exercise.

This description comes directly from the study's public registry record.

Talk to the study team

Neil Eves, PhD  ·  (250) 807-9676  ·  neil.eves@ubc.ca

Cassidy Williams, BHK  ·  (250) 807-9676  ·  cwilli08@student.ubc.ca

Always discuss trial participation with your own doctor first.

Locations (1)

University of British ColumbiaKelowna, British Columbia, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07285031